In the episode, we’re talking about vector design and delivery for gene therapies. The field of cell and gene therapies is advancing, but there are still challenges with delivery vectors that need to be addressed. In this GENCast, experts discuss current immunogenicity hurdles, evolving DMPK strategies, and a new generation of bioanalytical tools that are contributing to the progress in the field.
This podcast is the third in a series. Don’t miss episode one Precision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene Therapies and episode two From Functional Genomics to Cell Therapy: The Role of CRISPR-based Gene Editing.
Podcast Guests:
Michelle Fraser, PhD
Head of Cell and Gene Therapy
Revvity
David Schaffer
Hubbard Howe Distinguished Professor
University of California, Berkeley
Nagendra Chemuturi, PhD
Senior Director, ADME
Eli Lilly
Arun Srivastava, PhD
Professor
University of Florida College of
Medicine
Produced with support from:
